| IIGZX | TEDRX | IIGZX / TEDRX | |
| Total Expense Ratio | 0.60 | 1.45 | 41% |
| Annual Report Gross Expense Ratio | 0.70 | 1.45 | 48% |
| Fund Existence | 11 years | 24 years | - |
| Gain YTD | 4.374 | 1.819 | 241% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 350M | 9.15B | 4% |
| Annual Yield % from dividends | 1.93 | 1.40 | 137% |
| Returns for 1 year | 3.96 | 1.56 | 253% |
| Returns for 3 years | 27.56 | 13.42 | 205% |
| Returns for 5 years | 19.82 | 0.08 | 24,446% |
| Returns for 10 years | 91.51 | 19.37 | 472% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTAX | 39.16 | 0.42 | +1.08% |
| Fidelity Advisor Biotechnology A | |||
| PREJX | 30.43 | 0.25 | +0.83% |
| Principal Real Estate Securities J | |||
| LVAQX | 21.62 | 0.17 | +0.79% |
| LSV Small Cap Value Investor | |||
| WSEFX | 39.41 | 0.28 | +0.72% |
| Boston Trust Walden Equity | |||
| AZMIX | 23.93 | 0.08 | +0.34% |
| Virtus NFJ Emerging Markets Value Ins | |||